back to Australia directory
australia clinical guidance

Addison's disease / adrenal insufficiency

An Australian evidence-boundary record for addison's disease / adrenal insufficiency. The Queensland PCCM has no matching chapter and this page deliberately makes no diagnostic or treatment recommendation.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. No clinical recommendation is provided for Addison's disease / adrenal insufficiency. Consult an exact current source issued for the patient's state, territory or specialist service.

Scope

The controlled Queensland Primary Clinical Care Manual, 12th edition, was checked through its complete contents and searchable text on 20 August 2026. No chapter matching Addison's disease / adrenal insufficiency was identified. This page therefore records the source gap only; it is not a clinical summary and must not be used to infer an Australian diagnostic, treatment, monitoring or referral pathway.
sources for this section:Queensland PCCM contents

The Bottom Line

  • No Australian recommendation about morning cortisol interpretation is made on this page because the PCCM source does not contain a matching topic chapter.
  • No Australian recommendation about stimulation testing is made on this page because the PCCM source does not contain a matching topic chapter.
  • No Australian recommendation about glucocorticoid replacement and sick-day dosing is made on this page because the PCCM source does not contain a matching topic chapter.
  • No Australian recommendation about adrenal-crisis treatment is made on this page because the PCCM source does not contain a matching topic chapter.
sources for this section:Queensland PCCM contents

How to locate an applicable pathway

1
Before applying any local pathway for morning cortisol interpretation, retrieve and verify an exact current primary source issued for the patient's state, territory or specialist service; this page supplies no recommendation in that decision area.
2
Before applying any local pathway for stimulation testing, retrieve and verify an exact current primary source issued for the patient's state, territory or specialist service; this page supplies no recommendation in that decision area.
3
Before applying any local pathway for glucocorticoid replacement and sick-day dosing, retrieve and verify an exact current primary source issued for the patient's state, territory or specialist service; this page supplies no recommendation in that decision area.
4
Before applying any local pathway for adrenal-crisis treatment, retrieve and verify an exact current primary source issued for the patient's state, territory or specialist service; this page supplies no recommendation in that decision area.
sources for this section:Queensland PCCM contents

Safety limitation

  • This page does not provide diagnostic, medicine, investigation or referral recommendations for Addison's disease / adrenal insufficiency; use an exact current condition-specific source and the applicable local pathway.
  • This evidence-boundary page does not define emergency red flags for Addison's disease / adrenal insufficiency. If a person is acutely unwell or deteriorating, use the current local emergency or retrieval pathway and condition-specific senior advice rather than this page.
sources for this section:Queensland PCCM contents

Queensland source boundary

The Queensland PCCM is a rural and remote Queensland implementation manual, not a comprehensive national topic library. Its contents are cited here solely to document the absent same-topic chapter. Other state, territory or specialty pathways may exist, but none was selected as claim evidence in this audit.
sources for this section:Queensland PCCM contents

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Queensland PCCM contents

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Contents and chapter scopeISBN 978-1-876560-22-5; Contents and chapter scope, pp. ii鈥搗 路 12th edition 2025, v1.03 with updates through 21 July 2026; exact chapter at printed pages ii鈥搗 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.